tachycardia semaglutide Frontiers Does semaglutide cause heart palpitations?
Description
GLP-1RA therapy was initially developed to treat type 2 diabetes
J Neurol, 2012
At higher doses of 8 mg and 12 mg, they experienced an average decline of 17% of their initial weight after 36 weeks
Therefore, complex mechanisms in both neurons and astrocytes may be involved in GLP-1-induced modulation of food intake in the NTS
For many patients, taste changes are most noticeable during the initial weeks of treatment or following dose increases , often coinciding with the period when gastrointestinal adverse effects such as nausea are most prominent
